Physician profile
Eric Serna
NPI 1861069502
$371.50
in general payments reported to CMS, 2019-2025
9 companies · $164 in 2025
The $164 reported for 2025 was more than what a typical provider received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $98.35 · 2024: $109 · 2025: $164.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $372.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $371.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $113.53 | 2024-2025 | Otezla, Repatha, Repatha |
| Novo Nordisk INC | $74.81 | 2025 | Wegovy |
| Bayer Healthcare Pharmaceuticals INC. | $47.19 | 2024-2025 | |
| Lilly USA, LLC | $31.52 | 2023 | Mounjaro |
| Genzyme Corporation | $24.96 | 2023 | |
| Merck Sharp & Dohme LLC | $22.37 | 2023 | Gardasil 9, Vaxelis, M-M-R II |
| Boston Scientific Corporation | $19.50 | 2023 | Infinion 16 |
| Abbvie INC. | $19.16 | 2024 | |
| Exact Sciences Corporation | $18.46 | 2025 | Cologuard Collection Kit |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Serna listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.